A

Arrowhead Pharmaceuticals
D

ARWR

14.410
USD
0.38
(2.71%)
مغلق
حجم التداول
46,478
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
1,978,743,345
أصول ذات صلة
ALNY
ALNY
3.98
(1.56%)
259.33 USD
C
CRSP
0.520
(1.38%)
38.220 USD
E
EDIT
0.01500
(0.93%)
1.63000 USD
I
IONS
1.100
(3.47%)
32.780 USD
MRNA
MRNA
0.600
(2.22%)
27.590 USD
N
NTLA
0.20000
(2.32%)
8.83000 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
S
SGMO
-0.01210
(-1.63%)
0.72800 USD
S
SRPT
0.740
(1.18%)
63.550 USD
VRTX
VRTX
2.22
(0.45%)
500.92 USD
المزيد
الأخبار المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.